journal article Nov 17, 2016

Factors associated with false-positive self-reported adherence to antihypertensive drugs

View at Publisher Save 10.1038/jhh.2016.80
Topics

No keywords indexed for this article. Browse by subject →

References
36
[1]
World Health Organization. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: 2003. Available at http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf Accessed: 20 January 2014.
[2]
Grymonpre RE, Didur CD, Montgomery PR, Sitar DS . Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 1998; 32: 749–754. 10.1345/aph.17423
[3]
Daniels T, Goodacre L, Sutton C, Pollard K, Conway S, Peckham D . Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest 2011; 140: 425–432. 10.1378/chest.09-3074
[4]
Choo PW, Rand CS, Inui TS, Lee ML, Canning C, Platt R . A cohort study of possible risk factors for over-reporting of antihypertensive adherence. BMC Cardiovasc Disord 2001; 1: 6. 10.1186/1471-2261-1-6
[5]
Medication Adherence

P. Michael Ho, Chris L. Bryson, John S. Rumsfeld

Circulation 2009 10.1161/circulationaha.108.768986
[6]
Koop E. Assessment and intervention to improve treatment adherence. In: Kotseva K, Oldridge N, Piepoli MF (eds). Evaluation of preventive cardiology. Chapter 26. In: Sielen S, DeBacken G, Piepoli MF, Wood D (eds) The ESC Textbook of Preventive Cardiology. Oxford University Press: Oxford, UK, 2015, pp 334–339.
[7]
Crowne DP, Marlowe D . A new scale of social desirability independent of psychopathology. J Consult Psychol 1960; 24: 349–354. 10.1037/h0047358
[8]
Nieuwkerk PT, de Boer-van der Kolk IM, Prins JM, Locadia M, Sprangers MA . Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding. Antivir Ther 2010; 15: 913–916. 10.3851/imp1644
[9]
Johnson TP, Fendrich M . A validation of the Crowne-Marlowe Social Desirability Scale. http://www.srl.uic.edu/publist/Conference/crownemarlowe.pdf.
[10]
Simoni JM, Frick PA, Lockhart D, Liebovitz D . Mediators of social support and antiretroviral adherence among an indigent population in New York City. AIDS Patient Care STDS 2002; 16: 431–439. 10.1089/108729102760330272
[11]
Welte JW, Russell M . Influence of socially desirable responding in a study of stress and substance abuse. Alcohol Clin Exp Res 1993; 17: 758–761. 10.1111/j.1530-0277.1993.tb00836.x
[12]
Zemore SE . The effect of social desirability on reported motivation, substance use severity, and treatment attendance. J Subst Abuse Treat 2012; 42: 400–412. 10.1016/j.jsat.2011.09.013
[13]
Beck AT, Steer RA, Brown GK . Manual for Beck Depression Inventory-II. Psychological Corporation: San Antonio, TX, USA, 1996.
[14]
Bautista LE, Vera-Cala LM, Colombo C, Smith P . Symptoms of depression and anxiety and adherence to antihypertensive medication. Am J Hypertens 2012; 25: 505–511. 10.1038/ajh.2011.256
[15]
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Aram V. Chobanian, George L. Bakris, Henry R. Black et al.

Hypertension 2003 10.1161/01.hyp.0000107251.49515.c2
[16]
Dupuy HJ. The Psychological General Well-Being (PGWB) Index. In: Wenger NK, Mattson ME, Furberg CD, Elinson J (eds). Assessment of Quality of Life in clinical trials of cardiovascular therapies. Le Jacq Publications: New York, NY, USA, 1984, pp 170–183.
[17]
Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.

Randolph C. Arnau, Mary W. Meagher, Margaret P. Norris et al.

Health Psychology 2001 10.1037/0278-6133.20.2.112
[18]
Chassany O, Dimenäs E, Dubois D, Wu A, Dupuy H . The Psychological General Well-Being Index (PGWBI) User Manual. MAPI Research Institute: Lyon, France, 2004. Available at http://178.23.156.107:8085/Instruments_files/USERS/pgwbi.pdf.
[19]
Anderson RB, Hollenberg NK, Williams GH . Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life. Arch Intern Med 1999; 159: 693–700. 10.1001/archinte.159.7.693
[20]
Erickson SR, Williams BC, Gruppen LD . Relationship between symptoms and health-related quality of life in patients treated for hypertension. Pharmacotherapy 2004; 24: 344–350. 10.1592/phco.24.4.344.33177
[21]
Tedla YG, Bautista LE . Drug side effect symptoms and adherence to antihypertensive medication. Am J Hypertens 2015; 29: 772–779. 10.1093/ajh/hpv185
[22]
Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J . Can simple clinical measurements detect patient noncompliance? Hypertension 1980; 2: 757–764. 10.1161/01.hyp.2.6.757
[23]
Sjölander M, Eriksson M, Glader EL . The association between patients’ beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey. BMJ Open 2013; 3: e003551. 10.1136/bmjopen-2013-003551
[24]
Butler JA, Peveler RC, Roderick P, Horne R, Mason JC . Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation 2004; 77: 786–789. 10.1097/01.tp.0000110412.20050.36
[25]
Thompson K, Kulkarni J, Sergejew AA . Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000; 42: 241–247. 10.1016/s0920-9964(99)00130-9
[26]
Sambath KA, Ramanujam R, Chinnaiyan P . Survival analysis: Kaplan-Meier and life table estimates for time to event clinical trial tuberculosis data. Concept Pure Appl Sci 2013; 1: 17–22.
[27]
Twisk J . Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide. Cambridge University Press: Cambridge, UK, 2003.
[28]
The meaning and use of the area under a receiver operating characteristic (ROC) curve.

J A Hanley, B J McNeil

Radiology 1982 10.1148/radiology.143.1.7063747
[29]
StataCorp. Stata Statistical Software: Release 13. StataCorp LP: College Station, TX, USA, 2013.
[30]
Adherence to Medication

Lars Osterberg, Terrence Blaschke

New England Journal of Medicine 2005 10.1056/nejmra050100
[31]
Chao J, Nau DP, Aikens JE . Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus. Clin Ther 2007; 29: 177–180. 10.1016/j.clinthera.2007.01.014
[32]
Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lönnqvist J . A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord 2008; 106 (1–2): 1–27. 10.1016/j.jad.2007.06.006
[33]
Biringer E, Mykletun A, Dahl AA, Smith AD, Engedal K, Nygaard HA et al. The association between depression, anxiety, and cognitive function in the elderly general population–-the Hordaland Health Study. Int J Geriatr Psychiatry 2005; 20: 989–997. 10.1002/gps.1390
[34]
Jonathan M, Michael GA . Multiple regression analysis and mass assessment: a review of the issues. Appraisal J 1988; 56: 89.
[35]
Hamilton GA . Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs 2003; 2: 219–228. 10.1016/s1474-5151(03)00058-6
[36]
Rothman KJ, Greenland S, Lash TL. Validity in epidemiologic studies. In: Rothman KJ, Greenland S, Lash TL (eds). Modern Epidemiology. Lippincott Williams & Wilkins: Philadelphia, PA, 2008, pp 129–147.
Metrics
27
Citations
36
References
Details
Published
Nov 17, 2016
Vol/Issue
31(5)
Pages
320-326
License
View
Cite This Article
Y G Tedla, L E Bautista (2016). Factors associated with false-positive self-reported adherence to antihypertensive drugs. Journal of Human Hypertension, 31(5), 320-326. https://doi.org/10.1038/jhh.2016.80